Publications Database

Frye R. E. , Rossignol D. A. (2016)

Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes.

Clinical Medicine Insights: Pediatrics

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Huffman L. , Elliott G. R. (2010)

Tetrahydrobiopterin as a novel therapeutic intervention for autism.

Neurotherapeutics

7(3), pp. 241-249

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Sreenivasula S. , Adams J. B. (2011)

Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

BMC Pediatrics

11(1), pp. 37

Read Abstract (New Window) Read Full (New Window)

Frye R. E. , Rossignol D. A. (2014)

Treatments for biomedical abnormalities associated with autism spectrum disorder.

Frontier in Pediatrics

eCollection 2014.

Read Abstract (New Window) Read Full (New Window)

Fudenberg H. (1996)

Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.

Biotherapy

9(1), pp. 143-147

Read Abstract (New Window)

Gasparotto F. M. et al.

Herbal medicine as an alternative treatment in autism spectrum disorder: A systematic review.

Current Drug Metabolism

Read Abstract (New Window)

Geier D. A. et al. (2011)

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Medical Science Monitor

17(6), pp. 15-123

Read Abstract (New Window)

Geier D. A. et al. (2008)

A prospective study of transsulfuration biomarkers in autistic disorders.

Neurochemical Research

34(2), pp. 386-393

Read Abstract (New Window)

Geier D. A. et al. (2008)

Biomarkers of environmental toxicity and susceptibility in autism.

Journal of the Neurological Sciences

280(1), pp. 101-108

Read Abstract (New Window)

Genuis S. J. , Bouchard T. P. (2010)

Celiac disease presenting as autism.

Journal of Child Neurology

25(1), pp. 114-119

Read Abstract (New Window)

Geraghty M. E. et al. (2010)

Nutritional interventions and therapies in autism: A spectrum of what we know: Part 2

ICAN: Infant, Child, and Adolescent Nutrition

2(2), pp. 120-133

Read Abstract (New Window)

Gesundheit B. et al. (2015)

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.

Medical Hypotheses

March, 84(3), pp. 169-177.

Read Abstract (New Window)

Ghalichi F. et al. (2016)

Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial.

World Journal of Pediatrics

November, 12(4), pp. 436-442

Read Abstract (New Window)

Ghanizadeh A. , Moghimi-Sarani E. (2013)

A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders.

BMC Psychiatry

13(1), pp. 196.

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. (2011)

c-Kit+ cells transplantation as a new treatment for autism: a novel hypothesis with important research and clinical implication.

Journal of Autism and Developmental Disorders

41(11), pp. 1591-1592.

Read Full (New Window)

Ghanizadeh A. (2012)

Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials.

Medical Gas Research

2(13),

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. , Derakhshan N. (2012)

N-acetylcysteine for treatment of autism, a case report.

Journal of Research in Medical Sciences

17(10), pp. 985-987.

Read Abstract (New Window)

Ghanizadeh A. (2011)

Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.

Neurochemical Research

36(5), pp. 922-923.

Read Abstract (New Window)

Gilbert D. (2008)

Regarding 'omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study'.

Biological Psychiatry

63(2), e13; author reply e15

Gillberg C. et al. (1986)

Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).

Developmental Medicine and Child Neurology

28(5), pp. 624-627

Read Abstract (New Window)